JPRN-UMIN000017365
Recruiting
未知
The study for personnlized medicine using sorafenib with genome analysis - The study of sorafenib
Department of Pharmaceutical sciences, Tohoku university hospital0 sites50 target enrollmentMay 1, 2015
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Hepatocellular carcinoma and renal cell carcinoma taking sorafenib
- Sponsor
- Department of Pharmaceutical sciences, Tohoku university hospital
- Enrollment
- 50
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
A research for personalized medicine using integrated database of ophthalmologic, environment and multi biometric information.Healthy and subjects with eye disorders (Age:20-70) who obtain informed consent.JPRN-UMIN000036747JST1,100
Completed
Not Applicable
Study for personalized medicine based on pharmacokinetics and pharmacodynamics concerned with therapeutic drug of nontuberculous mycobacterium.JPRN-UMIN000020406Center for Infectious Disease and Infection Control10
Active, not recruiting
Phase 1
An exploratory study of sorafenib for patients listed for transplantation due to HCCPatients >18 years with hepatocellular carcinoma, on waiting list for liver transplantationMedDRA version: 12.1Level: LLTClassification code 10019829Term: Hepatocellular carcinoma recurrentMedDRA version: 12.1Level: LLTClassification code 10019830Term: Hepatocellular carcinoma resectableEUCTR2010-024306-36-SEVästra Götalandsregionen21
Recruiting
Not Applicable
A study of polymorphism on cognitive decline in elderly breast cancer patients.Breast CancerJPRN-UMIN000050415Aichi Cancer Center Hospital100
Not yet recruiting
Phase 2
A clinical study on Parsiaoshan in treatment of kidney stoneHealth Condition 1: N200- Calculus of kidneyCTRI/2021/03/032231Central Council of Unani Medicine New Delhi